Trial Profile
A Phase II Trial of Pancreaticoduodenectomy Plus Postoperative Cisplatin, Interferon Alfa-2b, and 5-FU Combined With Radiation Treatment for Patients With Resected Pancreatic Adenocarcinoma.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Interferon alpha-2b (Primary) ; Cisplatin; Fluorouracil
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 14 Feb 2012 Actual initiation date changed from 1 May 2003 to 1 May 2002 as reported by ClinicalTrials.gov.
- 14 Feb 2012 Actual initiation date changed from 1 May 2003 to 1 May 2002 as reported by ClinicalTrials.gov.
- 14 Feb 2012 Actual patient number (29) added as reported by ClinicalTrials.gov.